{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:05:08Z","timestamp":1772935508492,"version":"3.50.1"},"reference-count":8,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"DOI":"10.25259\/ijdvl_329_2024","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T06:47:01Z","timestamp":1721976421000},"page":"233-235","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multifocal pyoderma gangrenosum induced by secukinumab in a patient with hidradenitis suppurativa"],"prefix":"10.25259","volume":"92","author":[{"given":"Beatriz","family":"Clemente-Hern\u00e1ndez","sequence":"first","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcial","family":"\u00c1lvarez-Salafranca","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Muelas-Rives","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Ollero-Domenche","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Gracia-Caza\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"10.25259\/IJDVL_329_2024\/ref-1","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1080\/09546634.2022.2062281","article-title":"The dark side of the moon: The immune-mediated adverse events of IL-17A\/IL-17R inhibition","volume":"33","author":"Messina","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.25259\/IJDVL_329_2024\/ref-2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ad.2018.04.003","article-title":"Paradoxical reactions to biologic therapy in psoriasis: A review of the literature","volume":"109","author":"Munera-Campos","year":"2018","journal-title":"Actas Dermosifiliog"},{"key":"10.25259\/IJDVL_329_2024\/ref-3","doi-asserted-by":"publisher","first-page":"e13150","DOI":"10.1111\/dth.13150","article-title":"Secukinumab-induced paradoxical hidradenitis suppurativa","volume":"33","author":"Navarro-Trivi\u00f1o","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.25259\/IJDVL_329_2024\/ref-4","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/1346-8138.14611","article-title":"Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab","volume":"46","author":"Jin","year":"2019","journal-title":"J Dermatol"},{"key":"10.25259\/IJDVL_329_2024\/ref-5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jdcr.2020.06.011","article-title":"Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab","volume":"6","author":"Petty","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.25259\/IJDVL_329_2024\/ref-6","doi-asserted-by":"publisher","first-page":"e13161","DOI":"10.1111\/dth.13161","article-title":"Pyoderma gangrenosum induced by secukinumab-A late paradoxical drug reaction","volume":"33","author":"Wollina","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.25259\/IJDVL_329_2024\/ref-7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/ced.15183","article-title":"Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: A case report and literature review","volume":"47","author":"Orita","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.25259\/IJDVL_329_2024\/ref-8","doi-asserted-by":"publisher","first-page":"2235040","DOI":"10.1080\/09546634.2023.2235040","article-title":"Pyoderma gangrenosum and Beh\u00e7et\u2019s-like disease induced by secukinumab: A paradoxical drug reaction","volume":"34","author":"Avc\u0131","year":"2023","journal-title":"J Dermatolog Treat"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/multifocal-pyoderma-gangrenosum-induced-by-secukinumab-in-a-patient-with-hidradenitis-suppurativa\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/multifocal-pyoderma-gangrenosum-induced-by-secukinumab-in-a-patient-with-hidradenitis-suppurativa\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:34:10Z","timestamp":1772868850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/multifocal-pyoderma-gangrenosum-induced-by-secukinumab-in-a-patient-with-hidradenitis-suppurativa\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":8,"alternative-id":["10.25259\/IJDVL_329_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_329_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"233"}}